From August 2017 through December 2020 dr Michal Kaczmarski held a position of a General Manager of the Polish Medicines Verification Organisation (PLMVS). At that time PLMVS successfully applied Robotic Process Automation for initial triage of alerts flagging potentially suspicious transactions. This experience made Michal believe in bots and human supervised automation and artificial intelligence in big data management.
Currently, Kaczmarski-Legal is dedicated to support its Clients in taking decisions on automation of fraud prevention and detection procedures.
“Robotic Process Automation (RPA), i.e., process automation technology based on bots is an attractive proposal for organisations interested in speeding up routine economic processes and improving their quality through algorithmization.
Prior to RPA implementation, these processes were usually time- consuming and human resource intensive. RPA frees the human potential and resources to perform more creative tasks while repetitive and mundane operations are shortened, and the quality of data and decisions based on them is improved by eliminating human errors.
Bots are robots installed on physical or virtual computers capable of mimicking actions previously performed by a human user“
Source: Kaczmarski, M. (2020) “Robotic Process Automation or Automation of Decision Making Models Based on Bots: Perspectives and Concerns on the Example of Applications in the Pharmaceutical Industry”, Studies and Work of the Collegium of Management and Finance , (179), pp. 43-56. Available at: https://econjournals.sgh.waw.pl/SiP/article/view/2480 (Accessed: 20February2021).